Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ACP5 |
| Upstream (Parents) |
|---|
| (<<) IFI30 → ACP5 |
| (<<) TFEC → ACP5 |
| (<<) LILRB4 → ACP5 |
| (<<) LAPTM5 → ACP5 |
| (<<) GPNMB → ACP5 |
| Downstream (Children) |
|---|
| ACP5 → MMP9 (>>) |
| ACP5 → SSX3 (>>) |
| ACP5 → TM7SF4 (>>) |
| ACP5 → CD22 (>>) |
| ACP5 → GH2///GH1///CSHL1///CSH2///CSH1 (>>) |
| ACP5 → NEUROG2 (>>) |
| ACP5 → HTR1A (>>) |
| ACP5 → DOK3 (>>) |
| ACP5 → NRIP3 (>>) |
| ACP5 → KCNMB2 (>>) |
| ACP5 → ZNF331 (>>) |
